IL1B and infection: In the late stage of infection (48 hpi), baicalin downregulates IRF3, thereby inhibiting the NF-κB pathway and the expression of downstream pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), ultimately achieving the dual effects of mitigating the inflammatory response and suppressing viral replication.